MEPROBAMATE AND APLASTIC ANAEMIA.
作者信息
CROMIE B W
出版信息
Br Med J. 1964 Feb 29;1(5382):562. doi: 10.1136/bmj.1.5382.562-e.
Abstract
摘要
相似文献
1
MEPROBAMATE AND APLASTIC ANAEMIA.眠尔通与再生障碍性贫血
Br Med J. 1964 Feb 29;1(5382):562. doi: 10.1136/bmj.1.5382.562-e.
2
[DRUG-INDUCED APLASTIC PANMYELOPATHY DUE TO CHLORAMPHENICOL IDIOSYNCRASY].[氯霉素特异体质所致药物性再生障碍性全髓细胞病]
Belg Tijdschr Geneesk. 1964 Feb 15;20:230-3.
3
Aplastic anaemia and agranulocytosis following chlorpromazine therapy.氯丙嗪治疗后出现的再生障碍性贫血和粒细胞缺乏症。
Med J Aust. 1960 Jan 23;47(1):130-1. doi: 10.5694/j.1326-5377.1960.tb105223.x.
4
LEUKAEMIA AND PHENYLBUTAZONE.白血病与保泰松
Br Med J. 1964 Jun 27;1(5399):1707. doi: 10.1136/bmj.1.5399.1707.
5
DRUG-INDUCED BLOOD DYSCRASIAS.药物性血液系统疾病
Dis Mon. 1963 Oct;24:1963:1-52.
6
APLASTIC ANEMIA FOLLOWING EXPOSURE TO BENZENE HEXACHLORIDE (LINDANE).接触六氯苯（林丹）后发生的再生障碍性贫血。
JAMA. 1965 Jul 12;193:110-4. doi: 10.1001/jama.1965.03090020024006.
7
[CHANGES IN THE BLOOD CAUSED BY DRUGS].
Ned Tijdschr Geneeskd. 1963 Nov 9;107:2122-3.
8
[ON CHLORAMPHENICOL-RELATED CASES OF PANCYTOPENIA].[关于氯霉素相关性全血细胞减少症病例]
Z Gesamte Inn Med. 1963 Aug 1;18:707-9.
9
10
[THE HEMATOLOGICAL RISK IN TREATMENT WITH HYPOCLYCEMIC SULFONAMIDES].[低血糖磺酰胺类药物治疗中的血液学风险]
Bull World Health Organ. 1964;31(1):95-100.
本文引用的文献
1
Agranulocytosis after Imipramine and Meprobamate.丙咪嗪和甲丙氨酯引发的粒细胞缺乏症
Br Med J. 1961 Jan 28;1(5221):257. doi: 10.1136/bmj.1.5221.257.
2
Detection and prevention of drug-induced blood dyscrasias.药物性血液系统疾病的检测与预防。
JAMA. 1962 Jul 14;181:114-9. doi: 10.1001/jama.1962.03050280044005e.
3
Drug-induced neutropenia and agranulocytosis.药物性中性粒细胞减少症和粒细胞缺乏症。
Practitioner. 1962 Feb;188:202-9.
4
Aplastic anemia after meprobamate (2-methyl-2-N-propyl-1,3-propanediol dicarbamate) therapy.眠尔通（2-甲基-2-N-丙基-1,3-丙二醇二氨基甲酸酯）治疗后发生的再生障碍性贫血。
N Engl J Med. 1957 Jun 27;256(26):1232-3. doi: 10.1056/NEJM195706272562607.
Zotero 插件